PKHD1L1 and pancreatic adenocarcinoma: Five cancer types, SKCM, pancreatic adenocarcinoma (PAAD), LUAD, liver hepatocellular carcinoma (LIHC), and stomach adenocarcinoma (STAD), showed significant correlations between the overall patient survival and PKHD1L1 mRNA expression (p < 0.01).